Literature DB >> 16341517

[Fluorosis--a forgotten entity. Case report of a woman with coxarthrosis and newly diagnosed fluorosis].

B Busse1, B Jobke, M Werner, M Fürst, W Rüther, G Delling.   

Abstract

The clinical manifestation of fluorosis has become rare over the past years. Although the use of fluoride medication in osteoporosis therapy remains controversial, past study results have led to a reduction in fluoride prescriptions. Several studies have shown minor biomechanical properties of newly built woven bone compared to original bone. Despite new prescription protocols, fluoride therapy should not be disregarded in the anamnesis of osteoporosis patients. In addition to conventional diagnostics in fluorosis, new techniques such as microanalysis and micro-CT-analysis show a diagnostic benefit. In this case, the edx-microanalysis results show an F concentration of over 1.0 wt% in bone. The ratio of bone to tissue volume, evaluated by micro-CT, is clearly elevated at 46% BV/TV. The histopathological preparation of the femoral head has made the possible effects of fluoride medication on bone visible and quantifiable. A direct causal relationship between coxarthrosis and fluoride medication, found both in our patient as well as in the literature, has not been demonstrated. In order to better understand the broad effects of fluoride medication in combination with coxarthrosis more studies are needed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16341517     DOI: 10.1007/s00292-005-0799-5

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  10 in total

1.  Distribution and excretion of radiofluoride in the human.

Authors:  C H CARLSON; W D ARMSTRONG; L SINGER
Journal:  Proc Soc Exp Biol Med       Date:  1960-06

Review 2.  Physicochemical aspects of fluoride-apatite systems relevant to the study of dental caries.

Authors:  E C Moreno; M Kresak; R T Zahradnik
Journal:  Caries Res       Date:  1977       Impact factor: 4.056

3.  [New possibilities for structural analysis of bone biopsies using microcomputer tomography (muCT)].

Authors:  G Delling; M Hahn; U Bonse; F Busch; O Günnewig; F Beckmann; H Uebbing; W Graeff
Journal:  Pathologe       Date:  1995-09       Impact factor: 1.011

4.  Endemic fluorosis in Turkish patients: relationship with knee osteoarthritis.

Authors:  S Savas; M Cetin; M Akdoğan; N Heybeli
Journal:  Rheumatol Int       Date:  2001-09       Impact factor: 2.631

5.  The effect of drinking water fluoridation on the fluoride content, strength and mineral density of human bone.

Authors:  E M Alhava; H Olkkonen; P Kauranen; T Kari
Journal:  Acta Orthop Scand       Date:  1980-06

6.  Fluoride salts are no better at preventing new vertebral fractures than calcium-vitamin D in postmenopausal osteoporosis: the FAVOStudy.

Authors:  P J Meunier; J L Sebert; J Y Reginster; D Briancon; T Appelboom; P Netter; G Loeb; A Rouillon; S Barry; J C Evreux; B Avouac; X Marchandise
Journal:  Osteoporos Int       Date:  1998       Impact factor: 4.507

7.  Abnormal bone mineralization after fluoride treatment in osteoporosis: a small-angle x-ray-scattering study.

Authors:  P Fratzl; P Roschger; J Eschberger; B Abendroth; K Klaushofer
Journal:  J Bone Miner Res       Date:  1994-10       Impact factor: 6.741

8.  Marked decrease in trabecular bone quality after five years of sodium fluoride therapy--assessed by biomechanical testing of iliac crest bone biopsies in osteoporotic patients.

Authors:  C H Søgaard; L Mosekilde; A Richards; L Mosekilde
Journal:  Bone       Date:  1994 Jul-Aug       Impact factor: 4.398

9.  The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis.

Authors:  Pierre J Meunier; Christian Roux; Ego Seeman; Sergio Ortolani; Janusz E Badurski; Tim D Spector; Jorge Cannata; Adam Balogh; Ernst-Martin Lemmel; Stig Pors-Nielsen; René Rizzoli; Harry K Genant; Jean-Yves Reginster
Journal:  N Engl J Med       Date:  2004-01-29       Impact factor: 91.245

10.  Effect of the fluoride/calcium regimen on vertebral fracture occurrence in postmenopausal osteoporosis. Comparison with conventional therapy.

Authors:  B L Riggs; E Seeman; S F Hodgson; D R Taves; W M O'Fallon
Journal:  N Engl J Med       Date:  1982-02-25       Impact factor: 91.245

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.